Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
Because of the pathological role of IL-6 in rheumatoid arthritis (RA), tocilizumab (TCZ), a humanized anti-IL-6 receptor monoclonal antibody, was expected to improve inflammation and joint destruction of RA. Indeed, randomized clinical trials demonstrated the clinical efficacy of TCZ as monotherapy...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
2012
|
| Online Erişim: | https://doi.org/10.4137/cmamd.s7371 https://journals.sagepub.com/doi/pdf/10.4137/CMAMD.S7371 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|